Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic-associated Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05332613
What this trial is testing

Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Weill Medical College of Cornell University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06937749
What this trial is testing

IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis (MASH)
Innovent Biologics (Suzhou) Co. Ltd. 165
Not applicableStudy completedNCT05804955
What this trial is testing

Alpha-Glutathione-S-Transferase (AlphaGST) and MARINA Index in Metabolic-Dysfunction-Associated-Steatotic-Liver-Disease (MASLD)

Who this might be right for
Fatty Liver
University of Campania Luigi Vanvitelli 260
Not applicableEnrolling By InvitationNCT06703450
What this trial is testing

Guerbet Liver Fibrosis

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
Icahn School of Medicine at Mount Sinai 50
Post-approval studies (Phase 4)UnknownNCT06501326
What this trial is testing

Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver DiseaseObesity
Affiliated Hospital of Nantong University 102
Not applicableStudy completedNCT06664684
What this trial is testing

Intermittent Fasting and Metabolic Dysfunction Associated Fatty Liver Disease

Who this might be right for
Intermittent FastingMetabolic Dysfunction-Associated Fatty Liver Disease
Istanbul Bilgi University 55
Not applicableLooking for participantsNCT07122700
What this trial is testing

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Who this might be right for
Metabolic Associated Fatty Liver DiseaseMetabolic Associated Steatotic Liver DiseaseCirrhosis, Liver+5 more
Foundation for the National Institutes of Health 400
Not applicableUnknownNCT06403332
What this trial is testing

Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal Associated Fatty Liver Disease, Implementation and Evaluation of Itnerventions to Reduce Its Burden.

Who this might be right for
Alcohol-related Liver DiseaseAlcohol Use DisorderMetabolic and Alcohol Related/Associated Liver Disease+1 more
Hospital Universitari Vall d'Hebron Research Institute 350
Not applicableStudy completedNCT06121999
What this trial is testing

Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults

Who this might be right for
Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD)Metabolic Associated-dysfunction Steatohepatitis (MASH)
Grand Valley State University 24
Large-scale testing (Phase 3)Looking for participantsNCT07165028
What this trial is testing

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company 4,500
Early research (Phase 1)Looking for participantsNCT07553663
What this trial is testing

Evaluating the Pharmacokinetics and Safety of Miricorilant

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated CirrhosisMetabolic Dysfunction-associated Steatotic Liver Disease (MASLD)+1 more
Corcept Therapeutics
Testing effectiveness (Phase 2)UnknownNCT05966025
What this trial is testing

Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Fatty Liver DiseaseFatty Liver
October 6 University 60
Not applicableLooking for participantsNCT05554224
What this trial is testing

Integrated Multi-omics Data for Personalized Treatment of Obesity-associated Fatty Liver Disease

Who this might be right for
NAFLDObesity, MorbidComorbidities and Coexisting Conditions
Institut Investigacio Sanitaria Pere Virgili 1,104
Not applicableNot Yet RecruitingNCT06923215
What this trial is testing

Glucose Disposal Rate as a Metric for Detection of Metabolic Associated Fatty Liver

Who this might be right for
MAFLD
Assiut University 30
Testing effectiveness (Phase 2)Study completedNCT06465186
What this trial is testing

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisNAFLD+2 more
Merck Sharp & Dohme LLC 85
Not applicableNot Yet RecruitingNCT07475962
What this trial is testing

Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes

Who this might be right for
Type 1 DiabetesLiver SteatosesMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+2 more
Institut de Recherches Cliniques de Montreal 100
Not applicableNot Yet RecruitingNCT07777198
What this trial is testing

Liver Stiffness Changes by iLivTouch to Predict Liver-Related Events in MAFLD

Who this might be right for
MAFLD
Beijing Friendship Hospital 2,303
Testing effectiveness (Phase 2)Active Not RecruitingNCT06108219
What this trial is testing

A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-associated Steatohepatitis (MASH)
Corcept Therapeutics 175
Not applicableUnknownNCT05520697
What this trial is testing

Exercise and Cerebral Hemodynamics in MAFLD.

Who this might be right for
Non-alcoholic Fatty Liver Disease
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 42
Large-scale testing (Phase 3)WithdrawnNCT06594523
What this trial is testing

Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis

Who this might be right for
MASHNASHMetabolic Dysfunction-associated Steatohepatitis+3 more
Sagimet Biosciences Inc.
Next Page
15